Holen Sie sich die Stockscreener-App
208.04
3.73%
-8.06
Vorhandelsmarkt:
206.66
-1.38
-0.66%
Schlusskurs vom Vortag:
$216.10
Offen:
$211.02
24-Stunden-Volumen:
2.75M
Relative Volume:
2.33
Marktkapitalisierung:
$29.01B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-91.08
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
-1.92%
1M Leistung:
-13.44%
6M Leistung:
+27.60%
1J Leistung:
+32.84%
1-Tages-Spanne:
$196.22
$212.99
1-Wochen-Bereich:
$196.22
$216.64
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
208.04 | 30.13B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
521.11 | 195.41B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
210.64 | 148.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
656.73 | 52.76B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
121.38 | 34.22B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.38 | 31.67B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera, Inc. $NTRA Shares Purchased by TD Asset Management Inc - MarketBeat
Handelsbanken Fonder AB Has $21.14 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Artisan Partners Limited Partnership Raises Holdings in Natera, Inc. $NTRA - MarketBeat
Forecasting The Future: 10 Analyst Projections For Natera - Sahm
Erste Asset Management GmbH Purchases 20,000 Shares of Natera, Inc. $NTRA - MarketBeat
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - The Motley Fool
Citigroup Inc. Sells 73,833 Shares of Natera, Inc. $NTRA - MarketBeat
Decoding Natera Inc (NTRA): A Strategic SWOT Insight - GuruFocus
Natera (NASDAQ:NTRA) Posts Quarterly Earnings Results, Beats Expectations By $0.81 EPS - MarketBeat
NTRA: Wells Fargo Maintains Rating, Raises Price Target to $215 - GuruFocus
Key facts: Natera Q4 2025 revenues rise 39.8%; new products launched; Baird raises price target - TradingView
Natera (NASDAQ:NTRA) Given New $215.00 Price Target at Wells Fargo & Company - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 8.7%Here's What Happened - MarketBeat
Why Natera (NTRA) Shares Are Falling Today - Finviz
Natera, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:NTRA) 2026-02-27 - Seeking Alpha
Evercore ISI Group Maintains Outperform Rating for Natera (NTRA), Raises Price Target | NTRA Stock News - GuruFocus
Natera: Sustained Outperformance, Conservative 2026 Guidance, and Innovation-Driven Upside Support Buy Rating and $285 Target - TipRanks
UBS Adjusts Natera Price Target to $290 From $280, Maintains Buy Rating - marketscreener.com
Natera (NTRA) Highlights Advances in Bladder Cancer Detection at ASCO Symposium - GuruFocus
Bladder-preserving cancer care: new Signatera MRD data from ASCO GU - Stock Titan
NTRA: Baird Raises Price Target to $257 with Outperform Rating | - GuruFocus
Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Natera Inc earnings beat by $0.88, revenue topped estimates - Investing.com Nigeria
Is It Time To Reassess Natera (NTRA) After Strong Multi Year Share Price Gains - simplywall.st
Natera (NTRA) Q4 2025 Earnings Call Transcript - The Globe and Mail
Natera, Inc. (NASDAQ:NTRA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Natera Inc earnings beat by $0.88, revenue topped estimates By Investing.com - Investing.com Canada
Natera Inc (NTRA) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
Natera, Inc. (NTRA) Announces Results From the SINERGY Trial - Bitget
Natera Q4 Earnings Call Highlights - MarketBeat
Natera (NTRA) Reports Strong Q4 2025 Growth and Positive Outlook - GuruFocus
Earnings Call Summary | Natera(NTRA.US) Q4 2025 Earnings Conference - 富途牛牛
Earnings call transcript: Natera Q4 2025 beats revenue expectations, stock rises - Investing.com
Natera (NTRA) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
Natera Q4 2025 slides: MRD volumes surge 56%, revenue tops $666M - Investing.com
Impressive Q4 Growth for Natera (NTRA) Exceeds Expectations - GuruFocus
Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance UK
Natera Q4 2025 slides: MRD volumes surge 56%, revenue tops $666M By Investing.com - Investing.com South Africa
Natera: Q4 Earnings Snapshot - KTEN
Earnings Summary: Natera Q4 - Benzinga
(NTRA) Natera Expects 2026 Revenue Range $2.62B$2.70B, vs. FactSet Est. of $2.61B - marketscreener.com
Natera Reports Fourth Quarter and Full Year 2025 Financial Results - bdtonline.com
Natera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Natera, NeoGenomics Unit End Patent Suit Over Lung Cancer Test - Bloomberg Law News
Natera earnings in focus as Japan expansion looms By Investing.com - Investing.com India
Westpac Banking Corp Grows Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by Westfield Capital Management Co. LP - MarketBeat
(NTRA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Natera Q4 2025 Earnings Call Transcript - MarketBeat
Natera: Fourth Quarter Financial Results Overview - Bitget
Assessing Natera (NTRA) Valuation After Positive SINERGY Trial Results In Head And Neck Cancer - simplywall.st
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Feb 03 '26 |
Sale |
230.77 |
1,639 |
378,229 |
137,847 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Feb 02 '26 |
Sale |
230.72 |
85,299 |
19,680,040 |
127,881 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Feb 03 '26 |
Sale |
230.77 |
4,725 |
1,090,379 |
123,156 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Feb 03 '26 |
Sale |
227.83 |
6,939 |
1,580,926 |
52,120 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Feb 03 '26 |
Sale |
231.02 |
3,594 |
830,279 |
178,081 |
| Sheena Jonathan | CO-FOUNDER |
Feb 03 '26 |
Sale |
230.77 |
435 |
100,384 |
263,161 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Feb 03 '26 |
Sale |
230.77 |
1,334 |
307,845 |
223,813 |
0.76%
4.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):